S. Stancliff

发表

Reducing the health consequences of opioid addiction in primary care.

R. D. Bruce, S. Bowman, Julie Eiserman, 2013, The American journal of medicine.

Provision of influenza and pneumococcal vaccines to injection drug users at a syringe exchange.

S. Stancliff, N. Salomon, D. Perlman, 2000, Journal of substance abuse treatment.

Capsule switching and capsule replacement in vaccine- preventable bacterial diseases

S. Basu, S. Stancliff, Duncan Smith-rohrberg, 2007 .

Harm Reduction: Front Line Public Health

S. Stancliff, H. Joseph, B. Phillips, 2015, Journal of addictive diseases.

S. Bowman, L. Beletsky, S. Stancliff, 2013, The American journal of medicine.

Evaluation of a Naloxone Distribution and Administration Program in New York City

T. M. Piper, S. Galea, S. Rudenstine, 2008, Substance use & misuse.

Methadone Maintenance Treatment (MMT):

S. Stancliff, J. Langrod, 2011 .

Syringe access for the prevention of blood borne infections among injection drug users

Scott Burris, Bruce Agins, J. Rich, 2003, BMC public health.

Methadone maintenance treatment (MMT): a review of historical and clinical issues.

S. Stancliff, J. Langrod, H. Joseph, 2000, The Mount Sinai journal of medicine, New York.

Overdose prevention for prisoners in New York: a novel program and collaboration

S. Stancliff, H. Zucker, H. Catania, 2015, Harm Reduction Journal.

Opioid Maintenance Treatment as a Harm Reduction Tool for Opioid-Dependent Individuals in New York City: The Need to Expand Access to Buprenorphine/Naloxone in Marginalized Populations

S. Stancliff, H. Joseph, S. Comer, 2012, Journal of addictive diseases.

Beliefs about methadone in an inner-city methadone clinic

S. Stancliff, E. Drucker, Julie Elana Myers, 2002, Journal of Urban Health.

Brief overdose education can significantly increase accurate recognition of opioid overdose among heroin users.

S. Stancliff, S. Comer, P. Roux, 2014, The International journal on drug policy.

Overdose prevention for injection drug users: Lessons learned from naloxone training and distribution programs in New York City

T. M. Piper, S. Galea, S. Rudenstine, 2007, Harm reduction journal.

The potential role of buprenorphine in the treatment of opioid dependence in HIV-infected individuals and in HIV infection prevention.

S. Basu, F. Altice, S. Stancliff, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Changes in Prescribed Opioid Dosages Among Patients Receiving Medical Cannabis for Chronic Pain, New York State, 2017-2019

Nicole Quackenbush, S. Stancliff, Danielle Greene, 2023, JAMA network open.

Buprenorphine maintenance therapy in opioid-addicted health care professionals returning to clinical practice: a hidden controversy.

S. Stancliff, J. Selzer, 2012, Mayo Clinic proceedings.

Cannabis as a Substitute for Opioids.

Nicole Quackenbush, S. Stancliff, Charles J. Gonzalez, 2019, JAMA.

Why 24 State and Territorial Health Officials Support Buprenorphine Deregulation.

S. Stancliff, H. Zucker, Danielle Greene, 2019, American Journal of Public Health.

Providing Naloxone to Substance Users for Secondary Administration to Reduce Overdose Mortality in New York City

S. Stancliff, D. Heller, Daliah I. Heller, 2007, Public health reports.

Syringe access and HIV incidence in the United States.

S. Stancliff, 2008, JAMA.

Regarding naltrexone for probationers and parolees.

S. Stancliff, 2007, Journal of substance abuse treatment.

While we dither, people continue to die from overdose: Comments on 'Clinical provision of improvised nasal naloxone without experimental testing and without regulatory approval: imaginative shortcut or dangerous bypass of essential safety procedures?'.

J. Rich, L. Beletsky, S. Stancliff, 2016, Addiction.